OSA screening before CGRP mAbs in chronic migraine

Key Points

• CGRP monoclonal antibodies may be less effective in chronic migraine patients with undiagnosed obstructive sleep apnea.
• Findings from a cohort of chronic migraine individuals indicate a significant overlap with OSA symptoms.
• Screening for OSA significantly improves management strategies and treatment outcomes for chronic migraines.
• Further research is needed to validate these findings in larger, diverse populations.